ImmunoGenesis, a clinical-stage biotechnology company developing innovative, science-driven immune therapies, and Cancer ...

Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Phase 1, first-in-human clinical trial ...

HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital pathology for the management of ...

AVB-101 Biomarker Data Readout Expected in 2026 Clinical Milestone Shared at AFTD Annual Caregiver Conference AviadoBio, a pioneering gene therapy company dedicated to developing and delivering ...

The Department of Health and Human Services said it is redirecting funding from what it calls a wasteful Biden-era project on ...

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has named Hui Liu as Director of Biostatistics to bolster its efforts as the ...

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited tumor-infiltrating lymphocytes (TILs) may be ...

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...

Ultrasound treatments are on the rise — and they’re not just for imaging anymore.

Following clearance from the FDA, a phase 1/2 study will assess OBI-902 in Trop-2-overexpressing solid tumors, with plans for ...

The Greater New Orleans region is making significant strides in advancing healthcare through innovative research, ...

The U.S. government is putting down $500 million toward the development of a “universal” vaccine—a shot designed to protect ...